Jeno Gyuris is a biotech professional with over thirty years of industry experience. He has held scientific leadership roles at several companies and focuses on translating discoveries into therapies.
At firms with a similar stage, sector and check size.
One email when Jeno's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJeno Gyuris is a biotech professional with over thirty years of industry experience. He has held scientific leadership roles at several companies and focuses on translating discoveries into therapies.
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Jeno in the subject. A warm intro from a founder Cure Ventures backed works better.
Mitotix Inc.; Chief Scientific Officer at AVEO Oncology; Chief Scientific Officer at Sporos Bioventures LLC; chief Scientific Officer at Tvardi; chief Scientific Officer at Asylia; chief Scientific Officer at Stellanova Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.